Glaxo-Wellcome
⚠️ Moderate Risk
FEI: 3003706950 • Makati • PHILIPPINES
FEI Number
3003706950
Location
Makati
Country
PHILIPPINESAddress
2266 Chino Roces Ave, , Makati, , Philippines
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/23/2005 | 64LDJ67CLOBETASOL PROPIONATE (GLUCOCORTICOID) | 118NOT LISTED | San Francisco District Office (SAN-DO) |
| 4/13/2005 | 62VDO18ACYCLOVIR (ANTI-VIRAL) | San Francisco District Office (SAN-DO) | |
| 8/22/2003 | 66JDB01LEVOTHYROXINE SODIUM (THYROID HORMONE) | 342PERSONALRX | Seattle District Office (SEA-DO) |
| 8/30/2002 | 63XAY99DIAGOSTIC AID (DRUGS) N.E.C. | 118NOT LISTED | San Francisco District Office (SAN-DO) |
Frequently Asked Questions
What is Glaxo-Wellcome's FDA import refusal history?
Glaxo-Wellcome (FEI: 3003706950) has 4 FDA import refusal record(s) in our database, spanning from 8/30/2002 to 6/23/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo-Wellcome's FEI number is 3003706950.
What types of violations has Glaxo-Wellcome received?
Glaxo-Wellcome has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Glaxo-Wellcome come from?
All FDA import refusal data for Glaxo-Wellcome is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.